Diferencia entre revisiones de «Template:Brain abscess antibiotics»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 2: | Línea 2: | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | *[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | ||
====Sinogenic or odontogenic source==== | ====Sinogenic or odontogenic source==== | ||
*[[Cefotaxime]] 2gm IV q6hr + [[metronidazole]] 500mg IV q6hr | |||
====Penetrating trauma or neurosurgical procedures==== | ====Penetrating trauma or neurosurgical procedures==== | ||
*[[Vancomycin]] 15mg/kg IV q12hr + [[ceftazidime]] 2gm IV q8hr | *[[Vancomycin]] 15mg/kg IV q12hr + [[ceftazidime]] 2gm IV q8hr | ||
Revisión del 20:37 6 jul 2015
Otogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Sinogenic or odontogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Penetrating trauma or neurosurgical procedures
- Vancomycin 15mg/kg IV q12hr + ceftazidime 2gm IV q8hr
Hematogenous source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
No obvious source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr